neoantigen prediction and computational perspectives towards clinical benefit
Published 4 years ago • 694 plays • Length 3:36Download video MP4
Download video MP3
Similar videos
-
4:58
expert report on neoadjuvant immune checkpoint inhibitors for melanoma
-
1:46
esmo immuno-oncology 2024: congress experts in the field invite you to share your research.
-
7:00
expert report on neoadjuvant immune checkpoint inhibitors for nsclc
-
3:38
immunotherapy biomarkers
-
6:02
esmo expert video report on current issues in immuno-oncology
-
3:35
neoantigen-based therapeutic cancer vaccines
-
25:23
targeting tumor mutations for personalized cancer immunotherapy
-
1:53
esmo oncologypro - presentation by dr. e. smyth
-
1:01
harnessing neoantigens for individualized cancer immunotherapy
-
3:21
nci's genomic data commons 2.0
-
0:45
highlighting the advantages of neoantigen mrna vaccines in melanoma
-
5:12
what are antigens and neoantigens?
-
19:03
next generation of immuno-oncology biomarkers
-
34:34
#esmo20 education weekend regional talks: latin america
-
2:20
neoantigens
-
0:27
immuno-oncology
-
1:26
the future of personalized, neoantigen cancer vaccines
-
0:52
how do cancer vaccines work?
-
2:20
neoantigens: promising targets for cancer therapy